Login / Signup
Getting the Timing Right: Controlling BCL-2 Inhibition as an Antifibrotic Therapy.
Joseph C Cooley
Elizabeth F Redente
Published in:
American journal of respiratory cell and molecular biology (2024)
Keyphrases
</>
pulmonary fibrosis
mesenchymal stem cells